Document is current
Any future updates will be listed below
-
Authors
Tian, Wen
Cao, Hua
Li, Xidan
Gong, Xing
Yu, Xinting
Li, Dongyun
Xie, Jing
Bai, Ying
Zhang, Dawei
Li, Xiaohong
Xu, Ping
Liu, Jiahui
Zhang, Bingwei
Ji, Xiaofei https://orcid.org/0000-0002-6104-1952
Dong, Huijie
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2200059445 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
Adjunctive PCSK9 Inhibitor Evolocumab in the Prevention of Early Neurological Deterioration in Non-cardiogenic Acute Ischemic Stroke: A Multicenter, Prospective, Randomized, Open-Label, Clinical Trial
https://doi.org/10.1007/s40263-024-01145-5
-
Funding
Funding for this research was provided by:
Dalian Medical Science Research Program ((2023DF016))
- License Information
-
More Information
Article History
Accepted: 26 November 2024
First Online: 5 January 2025
Declarations
:
: This study was funded by Dalian Medical Science Research Program (2023DF016).
: The authors declare no conflicts of interest in this study.
: The clinical data will be available at the ResMan website () within 5–24 months after the research results are published.
: This study was approved by the Ethics Committee of the First Affiliated Hospital of Dalian Medical University (Approval number: YJ-KS-KY-2023-193) and performed in accordance with the tenets of the Declaration of Helsinki. The Data Monitoring Committee of the First Affiliated Hospital of Dalian Medical University monitored the progress of the trial.
: Every patient recruited from six clinical centers provided written informed consent before participation.
: Not applicable.
: Not applicable.
: W.T., H.C., X.L., and X.G.: data analysis, manuscript writing, and manuscript final editing. X.Y., D.L., X.J., Y.B., D.Z., X.L., P.X., J.L., and B.Z.: study design and data acquisition. H.D. and X.J.: study design, data analysis, manuscript final editing, and manuscript revision. All authors contributed to the article and approved the submitted version. X.J. acted as guarantor.
